EverSource Wealth Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48K | Sell |
171
-1,267
| -88% | -$25.8K | ﹤0.01% | 3296 |
|
|
2025
Q1 | $26.1K | Buy |
1,438
+153
| +12% | +$2.78K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $32.5K | Buy |
1,285
+878
| +216% | +$22.2K | ﹤0.01% | 1377 |
|
|
2024
Q3 | $13.8K | Hold |
407
| – | – | ﹤0.01% | 1685 |
|
|
2024
Q2 | $15.5K | Sell |
407
-11
| -3% | -$419 | ﹤0.01% | 1626 |
|
|
2024
Q1 | $15.6K | Buy |
418
+379
| +972% | +$14.2K | ﹤0.01% | 1483 |
|
|
2023
Q4 | $1.55K | Buy |
+39
| New | +$1.55K | ﹤0.01% | 2257 |
|